Sleep Restriction and Postprandial Lipemia

Sponsor
University of Missouri-Columbia (Other)
Overall Status
Recruiting
CT.gov ID
NCT05713370
Collaborator
(none)
12
2
4
12
6
0.5

Study Details

Study Description

Brief Summary

Sleep restriction increases overnight and early morning NEFA levels, which are correlated with whole-body decreases in insulin sensitivity, consistent with the observed impairment of intracellular insulin signaling. Adipose tissue biopsies from sleep restricted subjects that are insulin stimulated have reduced phosphorylation of protein kinase B (pAKT). This protein is involved in suppression of intracellular lipolysis and NEFA release.

Aerobic exercise has beneficial effects on postprandial lipemia and insulinemia in normal-weight and obese individuals. Acute moderate-intensity aerobic exercise (30-90 min) performed 12-18 h before an oral fat tolerance test or mixed meal test reduces postprandial TG and insulin concentrations. This response is largely dependent upon the exercise-induced energy deficit as the response is abolished when the calories expended during exercise are replaced.

However, it is not known if sleep restriction will interfere with the beneficial effects of prior exercise on postprandial lipemia. The aim of this project is to investigate if sleep restriction negates the positive effect that exercise has on postprandial lipemia. It is hypothesized that sleep restriction will negate the beneficial effects of prior exercise on postprandial lipemia. Additionally sleep restriction will result in a worsening of the lipid profile compared to no exercise.

For the proposed study, the investigators will use a repeated measures ANOVA (4 study conditions (no exercise+ sleep restriction, no exercise+normal sleep, exercise+normal sleep, exercise+sleep restriction) x time will be used to analyze changes in NEFA and TG concentrations while a one way ANOVA will be used to analyze area under the curve of the NEFA and TG concentrations.

Condition or Disease Intervention/Treatment Phase
  • Dietary Supplement: high fat meal
N/A

Detailed Description

In the postprandial period, adipocytes respond to the increased insulin levels by suppressing intracellular triglycerides (TG) lipolysis and by increasing extracellular lipolysis by transporting lipoprotein lipase from intracellular vesicles to the surface of the endothelium. This results in decreased free fatty acids (FFA) release into the plasma and increased absorption of lipoprotein TGs, particularly those in chylomicrons and VLDLs.

Sleep restriction increases overnight and early morning NEFA levels, which are correlated with whole-body decreases in insulin sensitivity, consistent with the observed impairment of intracellular insulin signaling. Adipose tissue biopsies from sleep restricted subjects that are insulin stimulated have reduced phosphorylation of protein kinase B (pAKT). This protein is involved in suppression of intracellular lipolysis and NEFA release. Sleep restriction can also alter whole body substrate metabolism such that there is a trend for increased lipid oxidation. Additionally, research examining the effects of short-term sleep restriction on circulating lipids have had mixed results. A number of studies have found decreases in fasting TG while other studies found no change in plasma TGs with sleep restriction.

Aerobic exercise has beneficial effects on postprandial lipemia and insulinemia in normal-weight and obese individuals. Acute moderate-intensity aerobic exercise (30-90 min) performed 12-18 h before an oral fat tolerance test or mixed meal test reduces postprandial TG and insulin concentrations. This response is largely dependent upon the exercise-induced energy deficit as the response is abolished when the calories expended during exercise are replaced.

However, it is not known if sleep restriction will interfere with the beneficial effects of prior exercise on postprandial lipemia. The aim of this project is to investigate if sleep restriction negates the positive effect that exercise has on postprandial lipemia. It is hypothesized that sleep restriction will negate the beneficial effects of prior exercise on postprandial lipemia. Additionally sleep restriction will result in a worsening of the lipid profile compared to no exercise.

For the proposed study, the investigators will use a repeated measures ANOVA (4 study conditions (no exercise+ sleep restriction, no exercise+normal sleep, exercise+normal sleep, exercise+sleep restriction) x time will be used to analyze changes in NEFA and TG concentrations while a one way ANOVA will be used to analyze area under the curve of the NEFA and TG concentrations.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
12 participants
Allocation:
Randomized
Intervention Model:
Crossover Assignment
Intervention Model Description:
Subjects will complete all arms of the study in a counterbalanced designSubjects will complete all arms of the study in a counterbalanced design
Masking:
None (Open Label)
Primary Purpose:
Prevention
Official Title:
Sleep Restriction and Postprandial Lipemia
Actual Study Start Date :
Jul 1, 2022
Anticipated Primary Completion Date :
Jul 1, 2023
Anticipated Study Completion Date :
Jul 1, 2023

Arms and Interventions

Arm Intervention/Treatment
Placebo Comparator: no exercise, no SR

75 g of glucose will be given at the beginning of the study day (the evening prior there will be no exercise the night before the study day, normal sleep (8 h))

Dietary Supplement: high fat meal
A high fat meal (milkshake) will be administered on the morning after the intervention of no exercise and no SR the night before.

Experimental: no exercise, SR

75 g of glucose will be given at the beginning of the study day (the evening prior there will be no exercise the night before the study day, 4 h of sleep the previous night)

Dietary Supplement: high fat meal
A high fat meal (milkshake) will be administered on the morning after the intervention of no exercise and no SR the night before.

Experimental: Exercise, no SR

75 g of glucose will be given at the beginning of the study day (the evening prior there will be 45 min of exercise the night before the study day, normal sleep (8 h))

Dietary Supplement: high fat meal
A high fat meal (milkshake) will be administered on the morning after the intervention of no exercise and no SR the night before.

Experimental: Exercise, SR

75 g of glucose will be given at the beginning of the study day (the evening prior there will be 45 min of exercise the night before the study day, 4 h of sleep the previous night)

Dietary Supplement: high fat meal
A high fat meal (milkshake) will be administered on the morning after the intervention of no exercise and no SR the night before.

Outcome Measures

Primary Outcome Measures

  1. area under the curve of fatty acids concentrations [4 hr]

    blood samples for free fatty acid concentrations will be taken every 1/2 hr for 4 hr

  2. area under the curve of triglycerides concentrations [4 hr]

    blood samples for triglyceride concentrations will be taken every 1/2 hr for 4 hr

Secondary Outcome Measures

  1. area under the curve of glucose concentrations [4 hr]

    blood samples for glucose concentrations will be taken every 1/2 hr for 4 hr

Eligibility Criteria

Criteria

Ages Eligible for Study:
21 Years to 45 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Overweight and obese men and women

  • 21-45 years of age

  • BMI of 25-35 kg/m2

  • Normal sleeping habits of 7-9 hours per night

Exclusion Criteria:
  • type 2 diabetic

  • diagnosed with cardiovascular disease

  • hypertensive

  • smokers

  • pregnant

  • taking lipid-lowering medications

  • sleep apnea

  • fragmented sleep

  • have any recent changes in hormonal birth control

  • night shift workers or take regular daytime naps

  • any medications known to impact metabolism, appetite, or sleep

  • any allergies to milk, ice cream, peanut butter and soy.

Contacts and Locations

Locations

Site City State Country Postal Code
1 University of Misouri Columbia Missouri United States 65211
2 University of Missouri Columbia Missouri United States 65211

Sponsors and Collaborators

  • University of Missouri-Columbia

Investigators

  • Principal Investigator: Jill Kanaley, PhD, University of Missouri-Columbia

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University of Missouri-Columbia
ClinicalTrials.gov Identifier:
NCT05713370
Other Study ID Numbers:
  • SR-PPL
First Posted:
Feb 6, 2023
Last Update Posted:
Feb 6, 2023
Last Verified:
Jan 1, 2023
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Feb 6, 2023